Literature DB >> 16670320

Roles of the alternative complement pathway and C1q during innate immunity to Streptococcus pyogenes.

Jose Yuste1, Sifot Ali, Shiranee Sriskandan, Catherine Hyams, Marina Botto, Jeremy S Brown.   

Abstract

Complement is important for innate immunity to the common bacterial pathogen Streptococcus pyogenes, but the relative importance of the alternative and classical pathways has not been investigated. Using mice and human serum deficient in either C1q, the first component of the classical pathway, or factor B, an important component of the alternative pathway, we have investigated the role of both pathways for innate immunity to S. pyogenes. C3b deposition on four different strains of S. pyogenes was mainly dependent on factor B. As a consequence opsonophagocytosis of S. pyogenes was reduced in serum from factor B-deficient mice, and these mice were very susceptible to S. pyogenes infection. In contrast, C3b deposition was not dependent on C1q for two of the strains investigated, H372 and H305, yet opsonophagocytosis of all four S. pyogenes strains was impaired in serum deficient in C1q. Furthermore, infection in C1q-deficient mice with strain H372 resulted in a rapidly progressive disease associated with large numbers of bacteria in target organs. These results demonstrate the important role of the alternative pathway and C1q for innate immunity to S. pyogenes and suggest that C1q-mediated innate immunity to at least some strains of S. pyogenes may involve mechanisms that are independent of C3b on the bacteria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670320     DOI: 10.4049/jimmunol.176.10.6112

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Streptococcus pyogenes Endopeptidase O Contributes to Evasion from Complement-mediated Bacteriolysis via Binding to Human Complement Factor C1q.

Authors:  Mariko Honda-Ogawa; Tomoko Sumitomo; Yasushi Mori; Dalia Talat Hamd; Taiji Ogawa; Masaya Yamaguchi; Masanobu Nakata; Shigetada Kawabata
Journal:  J Biol Chem       Date:  2017-01-30       Impact factor: 5.157

2.  Distinct different contributions of the alternative and classical complement activation pathway for the innate host response during sepsis.

Authors:  Katja Dahlke; Christiane D Wrann; Oliver Sommerfeld; Maik Sossdorf; Peter Recknagel; Svea Sachse; Sebastian W Winter; Andreas Klos; Gregory L Stahl; Yuanyuan Xu Ma; Ralf A Claus; Konrad Reinhart; Michael Bauer; Niels C Riedemann
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

3.  The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype.

Authors:  Jose Yuste; Suneeta Khandavilli; Naadir Ansari; Kairya Muttardi; Laura Ismail; C Hyams; Jeffrey Weiser; Timothy Mitchell; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

Review 4.  Complement and periodontitis.

Authors:  George Hajishengallis
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

5.  Staphylococcal proteases aid in evasion of the human complement system.

Authors:  Monika Jusko; Jan Potempa; Tomasz Kantyka; Ewa Bielecka; Halie K Miller; Magdalena Kalinska; Grzegorz Dubin; Peter Garred; Lindsey N Shaw; Anna M Blom
Journal:  J Innate Immun       Date:  2013-07-03       Impact factor: 7.349

6.  CovR Regulates Streptococcus mutans Susceptibility To Complement Immunity and Survival in Blood.

Authors:  Lívia A Alves; Ryota Nomura; Flávia S Mariano; Erika N Harth-Chu; Rafael N Stipp; Kazuhiko Nakano; Renata O Mattos-Graner
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

7.  Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae.

Authors:  Martina M Ochs; William Bartlett; David E Briles; Bryony Hicks; Audra Jurkuvenas; Peggy Lau; Bing Ren; Amanda Millar
Journal:  Microb Pathog       Date:  2007-10-11       Impact factor: 3.738

8.  Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.

Authors:  Jose Yuste; Ashwin Sen; Lennart Truedsson; Göran Jönsson; Liang-Seah Tay; Catherine Hyams; Helen E Baxendale; Fiona Goldblatt; Marina Botto; Jeremy S Brown
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

9.  Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine.

Authors:  Reshmi Mukerji; Shaper Mirza; Aoife M Roche; Rebecca W Widener; Christina M Croney; Dong-Kwon Rhee; Jeffrey N Weiser; Alexander J Szalai; David E Briles
Journal:  J Immunol       Date:  2012-10-26       Impact factor: 5.422

10.  Cytokine production by human leukocytes with different expressions of natural antiviral immunity and the effect of antibodies against interferons and TNF-alpha.

Authors:  Beata Orzechowska; Zenon Antoszków; Iwona Siemieniec; Maria Lorenc; Bogna Jatczak; Zofia Błach-Olszewska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-03-20       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.